THOMAS JAMES DOYLE - 27 Jan 2026 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role
SVP, Finance & Accounting
Signature
Teresa Bair, Attorney-in-fact for Thomas Doyle
Issuer symbol
KURA
Transactions as of
27 Jan 2026
Net transactions value
-$60,426
Form type
4
Filing time
27 Jan 2026, 21:35:04 UTC
Previous filing
06 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
DOYLE THOMAS JAMES SVP, Finance & Accounting C/O KURA ONCOLOGY, INC., 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO Teresa Bair, Attorney-in-fact for Thomas Doyle 27 Jan 2026 0001910331

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KURA Common Stock Sale $18,834 -2,226 -1.5% $8.46 150,083 27 Jan 2026 Direct F1
transaction KURA Common Stock Sale $9,425 -1,114 -0.74% $8.46 148,969 27 Jan 2026 Direct F2
transaction KURA Common Stock Sale $5,880 -695 -0.47% $8.46 148,274 27 Jan 2026 Direct F3
transaction KURA Common Stock Sale $18,834 -2,226 -1.5% $8.46 146,048 27 Jan 2026 Direct F4
transaction KURA Common Stock Sale $7,454 -881 -0.6% $8.46 145,167 27 Jan 2026 Direct F5
holding KURA Common Stock 500 27 Jan 2026 spouse's 401(k)
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/24.
F2 Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/16/23.
F3 Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22.
F4 Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/25.
F5 Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/7/22.